Director and Staff

feldmanEva Feldman, M.D., Ph.D., F.A.A.N.

Director

Throughout her career, Dr. Eva Feldman, M.D., Ph.D., F.A.A.N., the Russell N. DeJong Professor of Neurology at the University of Michigan, has made it her mission to use scientific discoveries to understand and cure human diseases.

In January 2008, Dr. Feldman was named the first Director of the A. Alfred Taubman Medical Research Institute, which was created to support fundamental research into a wide range of human diseases. Under her leadership, the Taubman Institute funds senior-level scientists in a diverse spectrum of diseases – adult and childhood cancer, ALS, diabetes, cardiovascular disease and hearing loss.

In her own work, Dr. Feldman is on the forefront of applying stem cell research to human disease. Most notably she is the Principal Investigator of the first clinical trial of intraspinal transplantation of stem cells in patients with ALS.

In addition to running an active clinical practice at the University of Michigan, Dr. Feldman directs a team of 30 scientists who collaborate to understand and find new treatments for a wide variety of neurological diseases, including ALS, diabetic neuropathy, Alzheimer’s disease, and muscular dystrophies.

She is the author of more than 260 articles, 59 book chapters and 3 books. She is the Principal Investigator of 4 major National Institutes of Health research grants, 3 private foundation grants and 5 clinical trials focused on understanding and treating neurological disorders, with an emphasis on ALS and diabetic neuropathy. She is President of the American Neurological Association and recent Past President of the Peripheral Nerve Society.

Dr. Feldman has received many honors including the Early Distinguished Career Award from the University of Michigan, several scientific achievement awards in the field of diabetes and in May of this year, was elected to the Johns Hopkins Society of Scholars. Additionally, she has been listed in Best Doctors in America for 10 consecutive years.

Among Dr. Feldman’s greatest accomplishments is her training of both scientists and neurologists. Eight scientists have received their Ph.D. degrees under her, she has trained 40 postdoctoral fellows in her laboratory to become neuroscientists, and 36 neurologists have trained under her to specialize in the understanding and treatment of neuromuscular diseases, with an emphasis on ALS.


fischhoffMarty Fischhoff, B.A.

Managing Director

Marty Fischhoff came to the University of Michigan Health System in 2008 to oversee administrative, programming, communications and development functions of the Taubman Institute. Prior to that, he was assistant managing editor at The Detroit News, where he worked for 20 years in a wide variety of capacities. He was the editor of Detroit Monthly for five years before that, winning the William White Award as editor of the best city magazine in its circulation class in the nation. He has worked in public relations, marketing, video production and wrote a best-selling guidebook to Detroit. He has participated in many community organizations, serving on the boards of Washtenaw Literacy, the International Institute of Metropolitan Detroit and D-PAN (which produces music videos for the deaf community).


stacey-sakowskiStacey Jacoby, Ph.D.

Deputy Managing Director

Stacey Sakowski Jacoby, Ph.D., joined the Taubman Institute as the Deputy Managing Director in 2011.  Her role includes supporting the operation of the organization and managing scientific programs and communications of the Taubman Institute.

Dr. Jacoby received her Ph.D. in Molecular Biology & Genetics from Wayne State University in 2006, where her graduate research training focused on the biochemical characterization and analysis of post-translational modifications of proteins involved in serotonin biosynthesis.  She joined the laboratory of Dr. Eva Feldman at the University of Michigan in 2006 as a postdoctoral research fellow, and then advanced to Research Investigator in 2011.  In the Feldman laboratory, she developed and utilized zebrafish models of amyotrophic lateral sclerosis (ALS) to understand the mechanisms of motor neuron degeneration and identify points for therapeutic intervention.  Dr. Jacoby is the author/co-author of 14 manuscripts.


Melissa Preddy, B.A., M.A.

Communications Director

Melissa Preddy joined the Taubman Institute in 2011 as Communications Director.  A veteran editor and writer, she worked as a reporter, columnist and editor for The Detroit News from 1995 to 2008, specializing in business journalism and personal finance.  As a freelance writer, her work has appeared in print and online for numerous news organizations ranging from Bankrate.com to Agence France-Presse to D Business magazine.   She has authored and presented training materials to other journalists via seminars and webinars nationwide.

Preddy received a B.A. in Communications and an M.A. in Journalism from The University of Michigan, and also was selected as a Knight-Wallace Fellow in Journalism 04-05 for her study proposal on the topic of financial anthropology.


Judith Bentley, B.B.A.

Executive Assistant

Judith Bentley is executive assistant to Dr. Feldman, responsible for grant and manuscript submissions, as well as daily correspondence and administrative activities for the Taubman Institute and the Program for Neurology Research and Discovery laboratory.  Boldt also assists Dr. Feldman in her work on  the Juvenile Diabetes Research Foundation Center for the Study of Complications in Diabetes.  She received a Bachelor of Business Administration degree from Eastern Michigan University in 2005. 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists